Retinal Pharmacotherapy

Description

Retinal Pharmacotherapy is the first comprehensive book devoted to pharmacologic agents and their rationale and mechanisms of action in selected retinal and uveitic diseases. Drs. Quan Dong Nguyen, Eduardo Buchele Rodrigues, Michel Eid Farah, and William F. Mieler lead an international team of expert contributors to present up-to-date knowledge of new drugs on the market, the science behind the drugs, evidence of how the drugs work, and the reasons why they are effective or not. In print and online at expertconsult.com, this user-friendly, all-in-one reference provides you with easy access to practical information on the effective and appropriate use of pharmacologic agents in the management of retinal diseases.

Key Features

•Includes online access to the fully searchable text at expertconsult.com.

•Covers all new and existing retinal drugs to keep you current in this expanding area of the treatment of retinal diseases.

•Discusses the background behind retinal drugs and the various pathways of how they work so you can make thoroughly informed clinical decisions.

•Presents 400 color photographs and line drawings that illustrate disease appearance before and after treatment and clarify difficult key concepts.

•Features contributors from Europe, North America, South America, the Middle East, Asia, and Australia for an international approach.

•Identifies and emphasizes key points clearly in each chapter to improve comprehension and make finding information easier.

Author Information

By Quan Dong Nguyen; Eduardo Buchele Rodrigues; Michel Eid Farah and William F Mieler, MD, Professor and Vice-Chairman, Department of Ophthalmology & Visual Sciences, University of Illinois at Chicago, IL, USA

Disclaimer

Your purchase entitles you to access the web site until the next edition is published, or until the current edition is no longer offered for sale by Elsevier, whichever occurs first. Elsevier reserves the right to offer a suitable replacement product (such as a downloadable or CD-ROM-based electronic version) should access to the web site be discontinued. Registration and use of the web site is subject to the terms of the non-transferable, limited license under which access to the site and its content is granted by Elsevier. Access to the site by individuals is limited to the first retail purchaser and may not be transferred to another party by resale, lending or other means.